Organisation for Oncology and Translational Research
5 clinical trials · Sponsor
◉ Watch Organisation for Oncology and Translational Research
| Record | Firm | Date |
|---|---|---|
| Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal Women (NCT01709370) | Organisation for Oncology and Translational Research | 2012-02-01 |
| Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy (NCT01088893) | Organisation for Oncology and Translational Research | 2009-11-01 |
| Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast Cancer (NCT00135018) | Organisation for Oncology and Translational Research | 2006-02-01 |
| Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer (NCT02025712) | Organisation for Oncology and Translational Research | |
| High Risk Breast Cancer Screening Program (NCT00509509) | Organisation for Oncology and Translational Research |
Track Organisation for Oncology and Translational Research automatically
Every clearance here is in the API, with alerts when new ones post.